1. Repository of OAI
Ελληνικά   English  

Browsing by Author Karabina, S. A.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 6 to 25 of 26 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Chondroitin sulfate glycosaminoglycans are essential for the cellular assembly and secretion of PAF-acetylhydrolase by human adherent monocytesTselepis, A. D.; Karabina, S. A.; Stengel, D.; Piedagnel, R.; Chapman, M. J.; Ninio, E.24-Nov-2015-
Compositional lipoprotein changes and low-density lipoprotein susceptibility to oxidation in chronic renal failure patients with heavy proteinuriaKarabina, S. A.; Pappas, H.; Miltiadous, G.; Bairaktari, E.; Christides, D.; Tselepis, A.; Elisaf, M.; Siamopoulos, K.24-Nov-2015-
Current methodologies for the estimation of LDL-cholesterol in hemodialysis patients, based on homogeneous HDL-C, homogeneous LDL-C, immunoseparation LDL-C and ApoB assaysBairaktari, E.; Elisaf, M. S.; Tzallas, C.; Spheropoulos, G.; Pappas, M.; Tselepis, A.; Karabina, S. A.; Siamopoulos, K. C.; Tsolas, O.24-Nov-2015-
Distribution of PAF-acetylhydrolase activity in human plasma low-density lipoprotein subfractionsKarabina, S. A.; Liapikos, T. A.; Grekas, G.; Goudevenos, J.; Tselepis, A. D.24-Nov-2015-
Effect of atorvastatin on the concentration, relative distribution, and chemical composition of lipoprotein subfractions in patients with dyslipidemias of type IIA and IIBTsimihodimos, V.; Karabina, S. A.; Tambaki, A.; Bairaktari, E.; Achimastos, A.; Tselepis, A.; Elisaf, M. S.24-Nov-2015-
Effect of atorvastatin on the concentration, relative distribution, and chemical composition of lipoprotein sulafractions in patients with dyslipidemias of type IIA and IIBTsimihodimos, V.; Karabina, S. A.; Tambaki, A.; Bairaktari, E.; Achimastos, A.; Tselepis, A.; Elisaf, M. S.24-Nov-2015-
The effect of moxonidine on plasma lipid profile and on LDL subclass distributionElisaf, M. S.; Petris, C.; Bairaktari, E.; Karabina, S. A.; Tzallas, C.; Tselepis, A.; Siamopoulos, K. C.24-Nov-2015-
Evaluation of five methods for determining low-density lipoprotein cholesterol (LDL-C) in hemodialysis patientsBairaktari, E.; Elisaf, M.; Tzallas, C.; Karabina, S. A.; Tselepis, A. D.; Siamopoulos, K. C.; Tsolas, O.24-Nov-2015-
Evaluation of five methods for determining low-density lipoprotein cholesterol (LDL-C) in hemodialysis patients(1)Bairaktari, E.; Elisaf, M. S.; Tzallas, C.; Karabina, S. A.; Tselepis, A. D.; Siamopoulos, K. C.; Tsolas, O.24-Nov-2015-
Glibenclamide improves postprandial hypertriglyceridaemia in type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levelsSkrapari, I.; Perrea, D.; Ioannidis, I.; Karabina, S. A.; Elisaf, M. S.; Tselepis, A. D.; Karagiannacos, P.; Katsilambros, N.24-Nov-2015-
High density lipoprotein changes in patients with microvascular anginaElisaf, M. S.; Karabina, S. A.; Tselepis, A. D.24-Nov-2015-
Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemiaKarabina, S. A.; Elisaf, M. S.; Bairaktari, E.; Tzallas, C.; Siamopoulos, K. C.; Tselepis, A. D.24-Nov-2015-
Increased PAF-acetylhydrolase activity in uremic patients: The influence of dialysis procedureMilionis, H.; Tselepis, A.; Karabina, S. A.; Vini, M.; Bairaktari, H.; Tziallas, C.; Elisaf, M. S.; Siamopoulos, K. C.24-Nov-2015-
Increased platelet reactivity to the aggregatory effect of platelet activating factor, in vitro, in patients with heterozygous familial hypercholesterolaemiaElisaf, M. S.; Karabina, S. A.; Bairaktari, E.; Goudevenos, J. A.; Siamopoulos, K. C.; Tselepis, A. D.24-Nov-2015-
LDL subfractions in patients with myocardial infarction: effect of smoking and beta-blocker treatmentTheodoraki, T. G.; Tsoukatos, D. C.; Karabina, S. A.; Rallidis, L. S.; Papageorgakis, H.; Tselepsis, A. D.24-Nov-2015-
Lipoprotein (a) and apolipoprotein (a) isoforms in patients with coronary artery disease documented by angiographyKatsouras, C. S.; Karabina, S. A.; Goudevenos, J. A.; Elisaf, M. S.; Tampaki, A. P.; Michalis, L. K.; Sideris, D. A.; Tselepis, A. D.24-Nov-2015-
Lipoprotein (a), apolipoprotein (a), phenotype and thyroid autoimmunity in patients with renal failureElisaf, M. S.; Katopodis, K.; Milionis, C.; Bairaktari, E.; Katsaraki, A.; Tselepis, A.; Karabina, S. A.; Tzallas, C.; Siamopoulos, K. C.24-Nov-2015-
PAF-acetylhydrolase is an antiinflammatory and antioxidant phospholipase A(2) that may be implicated in atherothrombosisTselepis, A. D.; Elisaf, M. S.; Goudevenos, J.; Karabina, S. A.; Tsoukatos, D.; Chapman, M. J.; Ninio, E.24-Nov-2015-
Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis proceduresMilionis, H. J.; Elisaf, M. S.; Karabina, S. A.; Bairaktari, E.; Tselepis, A. D.; Siamopoulos, K. C.24-Nov-2015-
Serum lipoprotein(a) concentrations and apolipoprotein(a) isoforms: association with the severity of clinical presentation in patients with coronary heart diseaseKatsouras, C. S.; Karabina, S. A.; Tambaki, A. P.; Goudevenos, J. A.; Michalis, L. K.; Tsironis, L. D.; Stroumbis, C. S.; Elisaf, M. S.; Sideris, D. A.; Tselepis, A. D.24-Nov-2015-
Showing results 6 to 25 of 26 < previous   next >